RXRX News and Press, Recursion Pharmaceuticals Inc. From 02/18/26

2026-02-18 05:20:31 ET Read the full article on Seeking Alpha For further details see: Recursion Pharmaceuticals and Applied Digital shares fall after Nvidia exits stakes

2026-02-17 09:35:22 ET More on short interest Most shorted large-cap stocks in January Least shorted large-cap stocks in January Quantum computing stocks see elevated bearish bets amid volatility Most and least shorted large cap tech stocks in January ...

2026-02-16 13:05:27 ET More on short interest report Most and least shorted mid-to mega-cap healthcare stocks in January Hims & Hers short interest climbs amid legal risk related to weight loss pill HE, OTTR draw highest short interest in utilities sector; BIP an...

2026-02-16 07:40:00 ET Cathie Wood’s ARK Invest ETFs continued a similar trend from the last week, rotating further into crypto-linked platforms, fintech, and gene-editing names while trimming exposure to software, digital advertising, and consumer internet names.... Read t...

2026-02-12 09:35:12 ET More on markets Long Bulls Dow Jones And U.S. Index Outlook: Hawkish NFP Sends Stocks Lower 3 Warning Signs The Stock Market Is Overdue For A Sharp Correction House votes to end Canada tariffs as six Republicans defy Trump SA an...

Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement...

2026-02-10 09:41:40 ET Recent Market Developments Highlight How AI Is Accelerating Gene Discovery, Editing, and Biological Manufacturing Denver, Colorado- As artificial intelligence (AI) continues to move beyond software and automation, its impact on genomics and gene editing is...

2026-02-07 15:55:00 ET What's the best next use of artificial intelligence (AI)? Plenty of people would say drug development. And they'd arguably be right. That's not something for down the road, though, when AI is more refined. Recursion Pharmaceuticals (NASDAQ: RXRX) is doing ...

2026-02-03 15:06:17 ET More on OpenAI, Recursion and Absci Absci Corporation: Drawing Potential Insights On ABS-101 And ABS-201 Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript Absci Corporation (ABSI) Presents at 44...

AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift Canada NewsWire Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER, BC , Jan. 29, 2026 /CNW/ --  Equity-Insider.com  News Commentary  – The global AI medical ...